| __timestamp | Corcept Therapeutics Incorporated | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 60118000 |
| Thursday, January 1, 2015 | 1361000 | 89690000 |
| Friday, January 1, 2016 | 2058000 | 105953000 |
| Sunday, January 1, 2017 | 3554000 | 175062000 |
| Monday, January 1, 2018 | 5215000 | 263389000 |
| Tuesday, January 1, 2019 | 5504000 | 313546000 |
| Wednesday, January 1, 2020 | 5582000 | 375181000 |
| Friday, January 1, 2021 | 5281000 | 466491000 |
| Saturday, January 1, 2022 | 5385000 | 577383000 |
| Sunday, January 1, 2023 | 6481000 | 606375000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical industry, understanding cost structures is crucial. This chart provides a fascinating comparison of the cost of revenue for Corcept Therapeutics Incorporated and Evotec SE from 2014 to 2023. Over this period, Corcept Therapeutics saw a steady increase in its cost of revenue, starting at just under $1 million in 2014 and reaching approximately $6.5 million by 2023. This represents a growth of over 600% in a decade.
In contrast, Evotec SE's cost of revenue surged from around $60 million in 2014 to over $600 million in 2023, marking a tenfold increase. This stark difference highlights Evotec's aggressive expansion strategy compared to Corcept's more measured approach. Such insights are invaluable for investors and industry analysts seeking to understand the financial dynamics of these two companies.
Cost of Revenue Comparison: Eli Lilly and Company vs Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Novo Nordisk A/S and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Merck & Co., Inc. and Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Biogen Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Cost of Revenue Trends: Pharming Group N.V. vs Evotec SE
Corcept Therapeutics Incorporated vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Corcept Therapeutics Incorporated and Xencor, Inc.
Mesoblast Limited vs Evotec SE: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Geron Corporation vs Evotec SE
Cost Insights: Breaking Down Evotec SE and Xencor, Inc.'s Expenses